Biliouris, Konstantinos <br/><br/>
A pre-clinical quantitative model predicts the pharmacokinetics/pharmacodynamics of an anti-BDCA2 monoclonal antibody in humans.  [electronic resource] 

 -  Journal of pharmacokinetics and pharmacodynamics  12 2018 
 - 817-827 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-8744 
<br/><br/><label>Standard No.: </label>10.1007/s10928-018-9609-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal, Humanized--pharmacology<br/>Body Weight<br/>Computer Simulation<br/>Drug Evaluation, Preclinical<br/>Humans<br/>Immunoglobulin G<br/>Lectins, C-Type--antagonists & inhibitors<br/>Lupus Erythematosus, Cutaneous--drug therapy<br/>Lupus Erythematosus, Systemic--drug therapy<br/>Macaca fascicularis<br/>Membrane Glycoproteins--antagonists & inhibitors<br/>Models, Biological<br/>Receptors, Immunologic--antagonists & inhibitors